Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism ROCK1 inhibitors(Rho-associated protein kinase 1 inhibitors), ROCK2 inhibitors(Rho-associated protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H18BN3O3 |
InChIKeyWTZMCUOBQPTERK-UHFFFAOYSA-N |
CAS Registry2379279-96-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | 01 Oct 2019 |